Patents by Inventor Jeffrey A. Sterling

Jeffrey A. Sterling has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230120880
    Abstract: Embodiments relate to a tablet comprising celecoxib and ciprofloxacin or a pharmaceutically acceptable salt thereof, and low viscosity hydroxypropyl methylcellulose having a viscosity of less than 150 cP, when measured as a 2% solution in water at 20° C.
    Type: Application
    Filed: October 18, 2022
    Publication date: April 20, 2023
    Applicant: Neurosense Therapeutics Ltd.
    Inventors: Alon Ben Noon, Jeffrey Sterling, Oron Yacoby-Zeevi, Sharon Cohen Vered
  • Publication number: 20220285003
    Abstract: The techniques described herein relate to computerized methods and apparatus for determining a dose injected into a user by one or more medication delivery devices. Data is accessed that is indicative of an injection event group that includes one or more injection events associated with one or more medication delivery devices. The injection event group is processed to determine the dose injected into the user based on one or more of whether the injection event is associated with a medication delivery device change, a dose size of one or more of the injection events, a position of one or more of the injection events in the injection event group, and/or a time period between one or more injection events to a next injection event in the injection event group.
    Type: Application
    Filed: August 25, 2020
    Publication date: September 8, 2022
    Inventors: Jeffrey Sterling ANDREWS, Xuanyao HE, Jie XUE
  • Publication number: 20210287794
    Abstract: Disclosed herein are systems and methods for remote prescription of medication-dosing regimens. One embodiment takes the form of a method that includes presenting, via a healthcare-professional-(HCP)-portal user interface of an HCP system, multiple medication-dosing regimens pertaining to a patient. Each presented medication-dosing regimen is associated with a respective different medication-dosing algorithm. The method also includes receiving, via the HCP-portal user interface, an HCP selection of at least one of the presented medication-dosing regimens. The method also includes transmitting, to a medical mobile application (MMA) on a mobile device associated with the patient, HCP-selected-regimen data indicative of the at least one HCP-selected medication-dosing regimen.
    Type: Application
    Filed: July 19, 2019
    Publication date: September 16, 2021
    Inventors: Rhett Guy ALDEN, Jeffrey Sterling ANDREWS, Jennal Lynn JOHNSON, James Harold PARSHALL, Harry Daniel TUNNELL, IV, Scott Allen WEIGAND, Kristin Marie WESTERFIELD
  • Patent number: 9013055
    Abstract: A kite based electricity generation system uses a kite that is tethered to a permanent magnet. The permanent magnet is slidably disposed within a housing with an electric coil disposed therein, such that sliding of the magnet within the housing slides the magnet within the coil and generates electricity. As the kite is subject to a wind load, the kite pulls the magnet through the coil toward a top of the housing. When the wind load decreases, a spring biases the magnet in a reverse direction, each time the magnet sliding within the coil and generating electricity. The housing pivots with respect to a base to which the housing is attached and may also rotate with respect to the base, such pivoting and rotation may generate additional electricity.
    Type: Grant
    Filed: January 20, 2014
    Date of Patent: April 21, 2015
    Inventor: Jeffrey Sterling Phipps
  • Patent number: 8987263
    Abstract: Basic esters of fatty alcohols of the general formula: R1-O—CO-A or pharmaceutically acceptable salts thereof, wherein R1 is C12-C24 alkyl or C10-C24 alkenyl, and A is a residue containing at least one acyclic or cyclic amino group and/or at least one heteroaromatic ring containing a tertiary or quaternary nitrogen atom, are anti-inflammatory and immunomodulatory agents, useful in the treatment of immunologically-mediated inflammation, as adjuvants for antigens involved in both cellular and humoral responses.
    Type: Grant
    Filed: October 9, 2003
    Date of Patent: March 24, 2015
    Inventors: Meir Shinitzky, Irun R. Cohen, Raanan Margalit, Yaacov Herzig, Jeffrey Sterling, Gyorgy Toth, Istvan Miskolczi, Ferenc Rantal, Tivadar Tamas
  • Publication number: 20150039475
    Abstract: A system for sampling and purchasing digital content includes at least one processor, at least one computer-readable tangible storage device, and program instructions stored on the at least one storage device for execution by the at least one processor. The program instructions include first program instructions configured to receive data indicative of a keyword. The program instructions further include second program instructions configured to identify digital media content associated with the keyword. The program instructions further include third program instructions configured to communicate data indicative of a hyperlink, wherein the hyperlink is configured to link to sample content associated with the digital media content. The program instructions further include fourth program instructions configured to receive payment confirmation. The program instructions further include fifth program instructions configured to communicate data indicative of instructions for accessing the digital media content.
    Type: Application
    Filed: August 1, 2014
    Publication date: February 5, 2015
    Inventor: Jeffrey Sterling
  • Patent number: 8759382
    Abstract: Disclosed are novel derivatives of propargyl-trifluoromethoxy-amino-benzothiazole which are effective in treating neurologic disorders, including Parkinson's disease and multiple sclerosis.
    Type: Grant
    Filed: September 29, 2011
    Date of Patent: June 24, 2014
    Assignee: Teva Pharmaceutical Industries Ltd.
    Inventors: Eliezer Falb, Jeffrey Sterling, Yaacov Herzig, Raphael Nudelman, Konstantin Ulanenko
  • Patent number: 8727252
    Abstract: A rock crusher is attached to a typical excavator that has a swing boom, an extension arm attached to the swing boom, and a bucket attached to the extension arm. The rock crusher has at least one blade fixedly attached within the bucket's interior and at least one anvil fixedly attached to the extension arm just above the bucket. At least one other blade is pivotally attached to the extension arm as well as to the swing boom via a linkage so that when the extension arm is drawn toward the boom by pulling back on the operator's stick, this second blade is crushingly pressed onto the material within the bucket.
    Type: Grant
    Filed: August 23, 2011
    Date of Patent: May 20, 2014
    Inventor: Jeffrey Sterling Phipps
  • Publication number: 20130172364
    Abstract: Disclosed are novel derivatives of propargyl-trifluoromethoxy-amino-benzothiazole which are effective in treating neurologic disorders, including Parkinson's disease and multiple sclerosis.
    Type: Application
    Filed: September 29, 2011
    Publication date: July 4, 2013
    Applicant: TEVA PHARMACEUTICAL INDUSTRIES LTD.
    Inventors: Eliezer Falb, Jeffrey Sterling, Yaacov Herzig, Raphael Nudelman, Konstantin Ulanenko
  • Patent number: 7976054
    Abstract: A hitch ball assembly attenuates the lateral forces experienced by a trailer while being towed by a tractor. A ball assembly has a flange with a neck extending upwardly therefrom and a hitch ball seated atop the neck. A wedge, having a pair of linear points, extends downwardly from the flange as does a threaded shank that passes through the wedge, the points being located on either side of the shank. The ball assembly is attached to a draw bar attached mount arm such that the shank passes through a bore in the mount arm with the points of the wedge seated within slots on an upper surface of the mount arm. A resilient bushing is received on the shank and abuts a lower surface of the mount arm, while a plate abuts the bushing, each held thereat by a locking nut threadably attached to an end of the shank.
    Type: Grant
    Filed: May 5, 2008
    Date of Patent: July 12, 2011
    Assignee: Growth Innovation, LLC
    Inventor: Jeffrey Sterling Phipps
  • Patent number: 7964751
    Abstract: Disclosed are enantiomers of amino-phenyl-acetic acid octadec-9-(Z)-enyl ester, and salts thereof, including pharmaceutical compositions, uses and a process for the manufacture thereof.
    Type: Grant
    Filed: February 25, 2008
    Date of Patent: June 21, 2011
    Assignee: Yeda Research and Development Co. Ltd.
    Inventors: Yaacov Herzig, Jeffrey Sterling, Vladimir Ioffe, Yuriy Raizi, Istvan Miskolczi, Andras Zekany
  • Publication number: 20100238064
    Abstract: A GPS-enabled radar detector capable of storing a database of points of interest is provided. The radar detector comprises a display capable of indicating not only the presence of a point of interest, but also an indication of the direction between the unit and a specified point of interest. In an alternate embodiment, the device comprises a display capable of displaying multiple, simultaneous alerts.
    Type: Application
    Filed: March 17, 2009
    Publication date: September 23, 2010
    Inventors: Vincent C. FORMANEK, Hiroshi Kainuma, Ricky J. Mucia, Jeffrey A. Sterling, Philip E. Thistlethwaite
  • Patent number: 7598420
    Abstract: The subject invention provides a pharmaceutical composition comprising N-propargyl-1(R)-aminoindan mesylate; a pharmaceutically acceptable carrier; and greater than 0.7 ppm but less than 30 ppm in total of a compound having the structure: and any salts of the compound.
    Type: Grant
    Filed: September 8, 2008
    Date of Patent: October 6, 2009
    Assignee: Teva Pharmaceutical Industries, Ltd.
    Inventors: Jeffrey Sterling, David Lerner, Harel Rosen, Leonid Bronov, Dalia Medini-Green, Berta Iosefzon, Tirtsah Berger-Peskin, Ramy Lidor-Hadas, Eliezer Bahar
  • Patent number: 7572834
    Abstract: The subject invention provides a pharmaceutical composition comprising N-propargyl-1(R)-aminoindan mesylate; a pharmaceutically acceptable carrier; and greater than 0.7 ppm but less than 30 ppm in total of a compound having the structure: and any salts of the compound.
    Type: Grant
    Filed: December 5, 2006
    Date of Patent: August 11, 2009
    Assignee: Teva Pharmaceutical Industries, Ltd.
    Inventors: Jeffrey Sterling, David Lerner, Harel Rosen, Leonid Bronov, Dalia Medini-Green, Berta Iosefzon, Tirtsah Berger-Peskin, Ramy Lidor-Hadas, Eliezer Bahar
  • Publication number: 20090131535
    Abstract: The subject invention provides derivatives of propargylamino indan (PAI) and propargylamino tetralin that selectively inhibit monoamine oxidase (MAO) in the brain, having the structure: wherein R1 is OC(O)R9 and R2 is H, wherein R9 is branched or unbranched C1 to C6 alkyl, aryl, or aralkyl, or R1 is OC(O)R4 and R2 is OC(O)R4, wherein R4 is branched or unbranched C1 to C6 alkyl, aryl, aralkyl or NR5R6, wherein R5 and R6 are each independently H, C1 to C8 alkyl, C6 to C12 aryl, C6 to C12 aralkyl or C6 to C12 cycloalkyl, each optionally substituted; wherein R3 is H or C1 to C6 alkyl; wherein n is 0 or 1; and wherein m is 1 or 2, or a pharmaceutically acceptable salt thereof. Additionally, the subject invention provides methods of treating neurological disorders using these compounds, uses of these compounds for the manufacture of medicaments for treating neurological disorders and processes for synthesis of these compounds.
    Type: Application
    Filed: January 21, 2009
    Publication date: May 21, 2009
    Inventors: Eran Blaugrund, Yaacov Herzig, Jeffrey Sterling
  • Publication number: 20080221209
    Abstract: Disclosed are enantiomers of amino-phenyl-acetic acid octadec-9-(Z)-enyl ester, and salts thereof, including pharmaceutical compositions, uses and a process for the manufacture thereof.
    Type: Application
    Filed: February 25, 2008
    Publication date: September 11, 2008
    Inventors: Yaacov Herzig, Jeffrey Sterling, Vladimir Ioffe, Yuriy Raizi, Istvan Miskolczi, Andras Zekany
  • Patent number: 7294739
    Abstract: This invention is directed to compounds of the following formula (I): wherein R is either: wherein R1 and R2 are as defined in the specification; the use of these compounds for treating inflammatory disorders; and pharmaceutical compositions comprising a therapeutically effective amount of the above-defined compounds.
    Type: Grant
    Filed: November 6, 2006
    Date of Patent: November 13, 2007
    Assignee: Teva Pharmacaetical Industries Ltd.
    Inventors: Yaacov Herzig, David Lerner, Jeffrey Sterling
  • Publication number: 20070095079
    Abstract: The present invention relates to a novel method for operating a thermal power plant or refrigeration cycle in which a spent low pressure working fluid is recycled to a high pressure vaporizer using temperature control within a heat exchanger instead of employing a working fluid feed pump. While the non-steady process is similar to a Rankine cycle, technically, it is no longer a Rankine cycle.
    Type: Application
    Filed: November 3, 2005
    Publication date: May 3, 2007
    Inventor: Jeffrey Sterling
  • Patent number: RE39616
    Abstract: This invention is directed to compounds of the following formula: wherein when a is 0, b is 1 or 2; when a is 1, b is 1, m is from 0-3, X is O or S, Y is halogeno, R1 is hydrogen C1-4 alkyl, R2 is hydrogen, C1-4 alkyl, or optionally substituted propargyl and R3 and R4 are each independently hydrogen, C1-6 alkyl, C6-12 aryl, C6-12 aralkyl each optionally substituted. This invention is also directed to the use of these compounds for treating depression, Attention Deficit Disorder (ADD), Attention Deficit and Hyperactivity Disorder (ADHD), Tourette's Syndrome, Alzheimer's Disease and other dementia's such as senile dementia, dementia of the Parkinson's type, vascular dementia and Lewy body dementia. This invention is further directed to a pharmaceutical composition comprising a therapeutically effective amount of the above-defined compounds and a pharmaceutically acceptable carrier.
    Type: Grant
    Filed: March 25, 2005
    Date of Patent: May 8, 2007
    Assignees: Teva Pharmaceutical Industries, Ltd., Yissum Research Development Company of the Hebrew University of Jerusalem, Technion Research and Development Foundation, Ltd.
    Inventors: Michael Chorev, Tamar Goren, Yacov Herzig, Jeffrey Sterling, Marta Weinstock-Rosin, Moussa B. H. Youdim
  • Patent number: D676345
    Type: Grant
    Filed: October 24, 2011
    Date of Patent: February 19, 2013
    Assignee: Cobra Electronics Corporation
    Inventors: Jeffrey A. Sterling, Philip E. Thistlethwaite, Hiroshi Kainuma, Byunghyuk Han, Hojae Jang, Dongmin Han